These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
207 related articles for article (PubMed ID: 27061568)
1. A phase II randomized controlled trial of nicotinamide for skin cancer chemoprevention in renal transplant recipients. Chen AC; Martin AJ; Dalziell RA; McKenzie CA; Lowe PM; Eris JM; Scolyer RA; Dhillon HM; Vardy JL; Bielski VA; Halliday GM; Damian DL Br J Dermatol; 2016 Nov; 175(5):1073-1075. PubMed ID: 27061568 [No Abstract] [Full Text] [Related]
2. A Phase 3 Randomized Trial of Nicotinamide for Skin-Cancer Chemoprevention. Chen AC; Martin AJ; Choy B; Fernández-Peñas P; Dalziell RA; McKenzie CA; Scolyer RA; Dhillon HM; Vardy JL; Kricker A; St George G; Chinniah N; Halliday GM; Damian DL N Engl J Med; 2015 Oct; 373(17):1618-26. PubMed ID: 26488693 [TBL] [Abstract][Full Text] [Related]
3. Reply to 'A phase II randomized controlled trial of nicotinamide for skin cancer chemoprevention in renal transplant recipients'. Yélamos O; Halpern AC; Weinstock MA Br J Dermatol; 2017 Feb; 176(2):551-552. PubMed ID: 27880000 [No Abstract] [Full Text] [Related]
4. Nicotinamide and skin cancer chemoprevention: The jury is still out. Gilmore SJ Australas J Dermatol; 2018 Feb; 59(1):6-9. PubMed ID: 29192960 [TBL] [Abstract][Full Text] [Related]
5. Nicotinamide for Skin-Cancer Chemoprevention. Drago F; Ciccarese G; Parodi A N Engl J Med; 2016 Feb; 374(8):789-90. PubMed ID: 26933858 [No Abstract] [Full Text] [Related]
6. Nicotinamide for Skin-Cancer Chemoprevention. Zhao Y N Engl J Med; 2016 Feb; 374(8):789. PubMed ID: 26933857 [No Abstract] [Full Text] [Related]
7. Nicotinamide for Skin-Cancer Chemoprevention. Chen AC; Martin AJ; Damian DL N Engl J Med; 2016 Feb; 374(8):790. PubMed ID: 26933856 [No Abstract] [Full Text] [Related]
8. Melanoma and nonmelanoma skin cancer chemoprevention: A role for nicotinamide? Minocha R; Damian DL; Halliday GM Photodermatol Photoimmunol Photomed; 2018 Jan; 34(1):5-12. PubMed ID: 28681504 [TBL] [Abstract][Full Text] [Related]
15. Authors' response to a reply to 'A phase II randomized controlled trial of nicotinamide for skin cancer chemoprevention in renal transplant recipients'. Damian DL; Martin AJ; Scolyer RA; Chen AC; Halliday GM Br J Dermatol; 2017 Feb; 176(2):552-553. PubMed ID: 27893156 [No Abstract] [Full Text] [Related]
16. Chemoprevention of keratinocyte carcinoma and actinic keratosis in solid-organ transplant recipients: Systematic review and meta-analyses. Tee LY; Sultana R; Tam SYC; Oh CC J Am Acad Dermatol; 2021 Feb; 84(2):528-530. PubMed ID: 32387631 [No Abstract] [Full Text] [Related]
17. Nicotinamide for prevention of nonmelanoma skin cancers: a change in practice? Nestor L; Clowry J; Molloy K; Connolly M; Salim A; Tobin AM Clin Exp Dermatol; 2017 Dec; 42(8):945-946. PubMed ID: 29044731 [No Abstract] [Full Text] [Related]
18. Systemic and topical retinoids in the management of skin cancer in organ transplant recipients. De Graaf YG; Euvrard S; Bouwes Bavinck JN Dermatol Surg; 2004 Apr; 30(4 Pt 2):656-61. PubMed ID: 15061851 [TBL] [Abstract][Full Text] [Related]
19. Skin cancer: Nicotinamide reduces new skin cancer risk. Sidaway P Nat Rev Clin Oncol; 2016 Jan; 13(1):4. PubMed ID: 26525684 [No Abstract] [Full Text] [Related]
20. Prevention of skin cancer and reduction of keratotic skin lesions during acitretin therapy in renal transplant recipients: a double-blind, placebo-controlled study. Bavinck JN; Tieben LM; Van der Woude FJ; Tegzess AM; Hermans J; ter Schegget J; Vermeer BJ J Clin Oncol; 1995 Aug; 13(8):1933-8. PubMed ID: 7636533 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]